Mist chemotherapy in the belly for resistant ovarian cancer
Part of Cancer, Digestive system, Hormones & metabolism, Women’s health & pregnancy clinical trials.
This study tests giving a chemotherapy drug (paclitaxel) as a fine mist directly into the belly using a small camera tube. It is for ovarian cancer that has stopped responding to standard IV chemo, and aims to fight the cancer where it is while possibly causing fewer side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman between 19 and 85 years old.
- You have ovarian, fallopian tube, or peritoneal cancer that is resistant to platinum-based chemotherapy (grew or returned within 6 months after treatment).
- You have already had at least 2 different IV chemotherapy treatments.
- The cancer is visible in your belly (abdomen) on scans, and you are not eligible for surgery to remove it.
- You have no more than one area of cancer spread outside the belly, and no bowel blockage.
- You are generally well enough for a short hospital stay and a laparoscopic procedure (small cuts in the belly).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 1 study tests a new way to deliver chemotherapy inside the abdomen (belly) using a pressurized aerosol during a procedure, along with standard blood (IV) chemotherapy. It may help people with advanced ovarian cancer whose tumors have not progressed but are not removable with surgery yet.
This trial tests a special chemotherapy delivery method called PIPAC (pressurized intraperitoneal aerosol chemotherapy) for ovarian cancer that has spread within the abdomen. The goal is to deliver cancer-fighting drugs more effectively directly to where the cancer is.
This trial tests a new way to give chemotherapy directly into the belly as a fine mist (called PIPAC) for people whose cancer has spread there. The goal is to see if it’s safe and helps shrink or control the cancer.
This study tests a new way to deliver chemotherapy directly into the abdomen (called PIPAC) for women with advanced ovarian cancer who cannot have surgery to remove all tumors. The goal is to see if this approach is safe and helps slow cancer growth.
This trial tests a new way to give chemotherapy – as a fine mist sprayed directly into the belly during a short laparoscopy (keyhole surgery). It is for people whose stomach, pancreas, or colon cancer has spread to the lining of the belly, and who haven't had much chemotherapy before.
This trial tests a new way to deliver chemotherapy directly into the abdomen using a spray (called PIPAC) in people with stomach cancer that has spread to the lining of the belly. The aim is to see if it can help control the cancer with fewer side effects.
Hear when a new Ovarian Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.